This video showcases the work of some of the companies who have gained contracts to develop new healthcare solutions, through two NHS East of England SBRI competitions: Managing long term health conditions and Patient safety

Featured companies include:

• Eykona Technologies who have identified a substantial and recognised unmet need in the objective measurement and characterisation of wounds such as diabetic ulcers. It is meeting this need through the use of a patented 3D imaging medical device based on cutting edge technology developed in the University of Oxford and consisting of a proprietary camera and software package. The project will deliver hand-held 3D imaging hardware suitable for initial evaluation by clinicians.
  
  
• Sonovia Ltd who has developed a novel ultrasonic patch technology for use in therapeutic and drug delivery applications for patients with chronic musculoskeletal conditions. The patch approach allows problem areas to be targeted to provide direct therapy from the passage of ultrasound combined with enhanced penetration of active substances such as anti-inflammatories and analgesics. The thin flexible patch will allow simple, safe and effective devices to be used in the comfort of patients' own homes.
  
  
• Cambridge Design Partnership who developed new technology to reduce the occurrence of Ventilator Associated Pneumonia (VAP) in the Intensive Care Unit. VAP is the most prevalent infection in the ICU, with a 10-15% incidence rate. Many people die unnecessarily of VAP every year in the UK, and the cost to the NHS of treating the condition runs into hundreds of millions of pounds. The new technology aims to fully humidify the breathing air while preventing the colonisation of bacteria.
  
  
• Oxford BioSignals whose technology is founded on evidence-based intelligent algorithms. Applications include patient health monitoring and cardiac safety. The Visensia patient monitoring systems fuse vital signs to deliver a proven predictive assessment of patients' health. At University of Pittsburgh Medical Centre in the 18 months prior to deployment in a step-down ward, there were more than 50 unexpected fatal cardiac arrests; in the 18 months since Visensia was introduced there have been none. The project aims to exploit wireless technology to make Visensia's life saving, real-time monitoring widely available as a low-cost, unobtrusive tool for nurses.